BOSCH J J ET AL: "MCSP/CD3-bispecific single-chain antibody construct engages CD4+ and CD8+ T cells for lysis of MCSP-expressing human uveal melanoma cells", INTERNET CITATION, 21 April 2010 (2010-04-21), XP002685799, Retrieved from the Internet: URL:http://www.abstractsonline.com/Plan/Vi ewAbstract.aspx?mID=2521&sKey=ef81a5fa-b15 c-4c4e-aa57-870b6479e274&cKey=a695d122-de2 0-451f-aeba-daf2b2a898f1&mKey={0591FA3B-AF EF-49D2-8E65-55F41EE8117E} [retrieved on 2012-10-23] (B1)

WOLF ET AL: "BiTEs: bispecific antibody constructs with unique anti-tumor activity", DRUG DISCOVERY TODAY, ELSEVIER, RAHWAY, NJ, US, vol. 10, no. 18, 15 September 2005 (2005-09-15), pages 1237-1244, XP005103829, ISSN: 1359-6446, DOI: 10.1016/S1359-6446(05)03554-3 (B1)

DIRK NAGORSEN ET AL: "Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab", EXPERIMENTAL CELL RESEARCH, ACADEMIC PRESS, US, vol. 317, no. 9, 10 March 2011 (2011-03-10), pages 1255-1260, XP028205663, ISSN: 0014-4827, DOI: 10.1016/J.YEXCR.2011.03.010 [retrieved on 2011-03-16] (B1)

EVAN P BOOY ET AL: "Monoclonal and bispecific antibodies as novel therapeutics", ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, BIRKHAEUSER-VERLAG, BASEL, CH, vol. 54, no. 2, 1 April 2006 (2006-04-01), pages 85-101, XP019200147, ISSN: 1661-4917, DOI: 10.1007/S00005-006-0011-5 (B1)

MILLER KATHY ET AL: "Design, construction, and in vitro analyses of multivalent antibodies", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 170, no. 9, 1 May 2003 (2003-05-01), pages 4854-4861, XP002508787, ISSN: 0022-1767 (B1)

OSHIMI ET AL: "Increased lysis of patient CD10-positive leukemic cells by T cells coated with anti-CD3 Fab' antibody cross-linked to anti-CD10 Fab' antibody.", BLOOD, vol. 77, no. 5, 1 March 1991 (1991-03-01), pages 1044-1049, XP055041891, ISSN: 0006-4971 (B1)

TUTT A ET AL: "TRISPECIFIC F(AB')3 DERIVATIVES THAT USE COOPERATIVE SIGNALING VIA THE TCR/CD3 COMPLEX AND CD2 TO ACTIVATE AND REDIRECT RESTING CYTOTOXIC T CELLS", THE JOURNAL OF IMMUNOLOGY, THE AMERICAN ASSOCIATION OF IMMUNOLOGISTS, US, vol. 147, no. 1, 1 July 1991 (1991-07-01), pages 60-69, XP000863699, ISSN: 0022-1767 (B1)

W. SCHAEFER ET AL: "Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 108, no. 27, 5 July 2011 (2011-07-05) , pages 11187-11192, XP055003817, ISSN: 0027-8424, DOI: 10.1073/pnas.1019002108 (B1)

WO-A1-2009/018386 (B1)

WO-A1-2009/080251 (B1)

WO-A1-2009/080253 (B1)

WO-A1-2009/080254 (B1)

WO-A1-2010/115551 (B1)

WO-A1-2010/115552 (B1)

WO-A1-2010/115589 (B1)

WO-A1-2010/136172 (B1)

WO-A1-2010/145792 (B1)

WO-A1-2010/145793 (B1)

WO-A2-2007/073499 (B1)

WO-A2-2007/075270 (B1)

WO-A2-2008/119567 (B1)

CHAN L A ET AL: "Variable region domain exchange in human IgGs promotes antibody complex formation with accompanying structural changes and altered effector functions", MOLECULAR IMMUNOLOGY, PERGAMON, GB, vol. 41, no. 5, 1 July 2004 (2004-07-01), pages 527-538, XP002519620, ISSN: 0161-5890, DOI: 10.1016/J.MOLIMM.2004.03.034 (B1)